SCHEMBL30823693

SCHEMBL30823693

NNC(=O)N(N[C@@H]1COc2ccccc2O1)C(=O)c1cc(-c2ccccc2)nn1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 8/20 0.43
▸ ALDH1A1 P00352 7/20 0.43
▸ HTT P42858 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CXCR5 P32302 1/20 0.42
▸ APLNR P35414 1/20 0.42
▸ CCR6 P51684 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ KMT2A Q03164 4/20 0.38
▸ HPGD P15428 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26341452 0.73 LMNA (0.60) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL26341442 0.73 LMNA (0.60) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL27171254 0.71 ALDH1A1 (0.45) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL30823695 0.71 ALDH1A1 (0.45) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL27171253 0.70 ALDH1A1 (0.46) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL27171246 0.69 EGFR (0.45) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL27171252 0.68 NTRK1 (0.46) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL30823700 0.67 PTPN1 (0.47) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL27172726 0.65 ALDH1A1 (0.63) LMNAALDH1A1HTTSMN1; SMN2CXCR5
SCHEMBL28203159 0.65 ALDH1A1 (0.67) LMNAALDH1A1HTTSMN1; SMN2CXCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof NORTHWEST A&F UNIVERSITY (CN) 2026-05-05 — — US disclosed
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF NORTHWEST A&F UNIVERSITY (CN) 2024-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof GSTP1, GSTO1, GSTA1 LMNA 4677/4885ALDH1A1 334/4885HTT 4506/4885
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GSTP1, CYP4F11, GSTA1 LMNA 4766/4885ALDH1A1 467/4885HTT 4122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback